Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53
Journal of Neuro-Oncology, 05/04/2012
Yamada S et al. – The results suggest that this protein–transduction method using the p53–nuclear localization sequence (NLS)–laminin (Ln)–11R peptide may become a promising glioma therapy as an alternative gene therapy.



